Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes

Table 3

Biomatrix Alpha versus LEADERS : propensity-adjusted MACE at 2 years with a landmark at day 3.

	CoCr-BP-BES (%)	SS-BP-BES (%)	Hazard ratio	value
MACE	7.25	9.34	0.76 [0.5–1.17]	0.259
- Cardiac death	1.29	3.26	0.39 [0.15–1.00]	0.064
- Myocardial infarction	2.82	2.36	1.17 [0.56–2.47]	0.721
- cd-TVR	4.57	6.39	0.65 [0.38–1.10]	0.152
All death	4.12	4.74	0.86 [0.49–1.52]	0.638
Target vessel MI	0.90	0.91	1.01 [0.28–3.59]	0.991
Definite or probable stent thrombosis	1.12	2.11	0.5 [0.17–1.45]	0.238
Any revasc	8.20	15.47	0.5 [0.34–0.73]	0.001
TVF (cardiac death or TV-MI or cd-TVR)	5.83	9.08	0.63 [0.4–1.00]	0.078
POCE (all death or any MI or any revasc)	11.69	18.39	0.6 [0.43–0.83]	0.006